Christopher Martell

CIK: 0001873465

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CADL

Candel Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CADL
Candel Therapeutics, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
32K shares-
CADL
Candel Therapeutics, Inc.
Jun 25, 2025
Award(A)
Indirect
111.3K shares at avg. $4.67$520K
CADL
Candel Therapeutics, Inc.
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
14.2K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	32,000	-	-	Direct
Jun 25, 2025	CADL Candel Therapeutics, Inc.	Award(A)	111,349	$4.67	$520,000	Indirect
Jun 17, 2025	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	14,240	-	-	Direct

1-3 of 3 transactions

About Martell Christopher

Martell Christopher (SEC CIK 0001873465) files insider reports with the SEC as Director of Candel Therapeutics, Inc. (CADL).

Signal8 holds 3 ownership filings by Martell Christopher, all Form 4s, filed between Jun 18, 2025 and Jun 24, 2026. Those filings report 3 transactions, from Jun 17, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Martell Christopher's filings is in NEEDHAM, MA.

Recent filings by Martell Christopher

Jun 23, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 25, 2025: Grant or award of CADL shares (Form 4, code A).
Jun 17, 2025: Grant or award of CADL derivative securities (Form 4, code A).

Other insiders filing for Candel Therapeutics, Inc. (CADL)

Loggia Nicoletta, Director
PAPA JOSEPH C, Director
Manning Paul B, Director
Tak Paul Peter, Chief Executive Officer
Zimmermann Martine, Director
Tyagarajan Seshu, Chief Technology Officer

How to read Form 4 transaction codes